Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis

Table 1 Compound–compound target network information

MOL ID	Compound	Drug	OB (%)	DL	Caco-2	Degree
MOL000358	Beta-sitosterol	SZY	36.91	0.75	1.32	28
MOL000449	Stigmasterol	SDH/SZY/SY	43.83	0.76	1.44	27
MOL008457	Tetrahydroalstonine	SZY	32.42	0.81	0.90	25
MOL000322	Kadsurenone	SY	54.72	0.38	0.82	23
MOL005430	Hancinone C	SY	59.05	0.39	0.74	18
MOL000296	Hederagenin	FL	36.91	0.75	1.32	17
MOL000546	Diosgenin	SY	80.88	0.81	0.82	16
MOL005465	AIDS180907	SY	45.33	0.77	0.73	10
MOL001559	Piperlonguminine	SY	30.71	0.18	0.95	9
MOL005440	Isofucosterol	SY	43.78	0.76	1.36	9
MOL005530	Hydroxygenkwanin	SZY	36.47	0.27	0.52	8
MOL000359	Sitosterol	MDP/SZY/SDH/ZX	36.91	0.75	1.32	3
MOL000953	CLR	SY	37.87	0.68	1.43	3
MOL001494	Mandenol	SZY	42.00	0.19	1.46	3
MOL002879	Diop	SZY	43.59	0.39	0.79	3
MOL005503	Cornudentanone	SZY	39.66	0.33	0.47	3
MOL001495	Ethyl linolenate	SZY	46.10	0.20	1.54	2
MOL001771	Poriferast-5-en-3beta-ol	SZY	36.91	0.75	1.45	2
MOL000275	Trametenolic acid	FL	38.71	0.80	0.52	1
MOL000282	Ergosta-7,22E-dien-3beta-ol	FL	43.51	0.72	1.32	1
MOL000283	Ergosterol peroxide	FL	40.36	0.81	0.84	1
MOL000211	Mairin	MDP	55.38	0.78	0.73	1
MOL005435	24-Methylcholest-5-enyl-3belta-O-gluCopyranoside_qt	SY	37.58	0.72	1.33	1
MOL005438	Campesterol	SY	37.58	0.71	1.34	1
MOL002883	Ethyl oleate (NF)	SZY	32.4	0.19	1.4	1
MOL005481	2,6,10,14,18-Pentamethylicosa-2,6,10,14,18-pentaene	SZY	33.4	0.24	1.94	1
MOL000831	Alisol B monoacetate	ZX	35.58	0.81	0.46	1

ISSN: 1749-799X